51³Ô¹ÏÍø

author

 
 

Meta

Ashleigh Furlong
Employees at the National Institute of Biomedical Research in Kinshasa, Congo, on Wednesday
WORLD / Science & Health
Jul 6, 2026
Experimental Ebola trial begins in Congo as death toll tops 500
The outbreak has already infected almost 1,600 people in Congo and seeded a small number of linked cases in neighboring Uganda.
A healthcare worker takes samples from a patient suffering from Ebola.
WORLD / Science & Health
Jun 26, 2026
Ebola scientists lack access to virus samples behind Congo¡¯s largest Bundibugyo outbreak
The issue highlights growing disputes over pathogen sharing and the difficulty of moving infectious materials across borders for research.
Tests for patients suffering from Alzheimer¡¯s disease are displayed at the Memory Center in Geneva in June 2023.
WORLD / Science & Health
Apr 16, 2026
Alzheimer¡¯s drugs targeting amyloid don¡¯t help, review finds
Despite successfully removing amyloid from the brain, the drugs don¡¯t improve cognitive function or slow its decline.
Astellas Pharma Chief Executive Officer Naoki Okamura
BUSINESS / Companies
Mar 11, 2026
Trump¡¯s drug cost push helps Astellas win higher price in Japan
Japan, where medicine prices are among the lowest in the most developed nations, has become a critical reference point in U.S. plans to match drug prices with other countries.
AstraZeneca and Daiichi Sankyo's drug Datroway extended survival in patients with a hard-to-treat form of breast cancer.
BUSINESS / Companies
Oct 7, 2025
Breast cancer patients lived longer on drug Datroway, says maker
The drug is said to have significantly improved survival and delayed disease progression in patients with a particularly hard to treat form of the disease.
Daiichi Sankyo is working on the next generation of targeted cancer drugs.
51³Ô¹ÏÍø / Science & Health
Sep 17, 2024
Daiichi wants to go it alone in search for targeted cancer drugs
Investors are betting on Daiichi¡¯s continued success, with its share price up 122% in the last five years.
People walk past the AstraZeneca booth during the first China International Supply Chain Expo (CISCE) in Beijing on Nov. 28, 2023.
BUSINESS / Companies
Sep 16, 2024
AstraZeneca¡¯s blockbuster drug scores major win in combatting bladder cancer
In patients with muscle-invasive bladder cancer, the drug Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care.

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon

SUSTAINABLE 51³Ô¹ÏÍø